|Application ||WB, E|
|Other Accession||P97863, P17924, Q0VCL6, NP_005587.2|
|Predicted||Bovine, Chicken, Mouse|
|Calculated MW||47442 Da|
|Antigen Region||255-283 aa|
|Other Names||Nuclear factor 1 B-type, NF1-B, Nuclear factor 1/B, CCAAT-box-binding transcription factor, CTF, Nuclear factor I/B, NF-I/B, NFI-B, TGGCA-binding protein, NFIB|
|Target/Specificity||This NFIB antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 255-283 amino acids from the Central region of human NFIB.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||NFIB Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Recognizes and binds the palindromic sequence 5'- TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
NFIB recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Persson, M., et al. Proc. Natl. Acad. Sci. U.S.A. 106(44):18740-18744(2009)
Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
Pierron, A., et al. Cancer Genet. Cytogenet. 195(1):66-70(2009)
Le Clerc, S., et al. J. Infect. Dis. 200(8):1194-1201(2009)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.